HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lidia Gil Selected Research

Azacitidine (5 Azacytidine)

1/2019Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lidia Gil Research Topics

Disease

11Infections
01/2022 - 12/2014
11Neoplasms (Cancer)
11/2019 - 11/2007
9Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 05/2007
7Leukemia
09/2020 - 11/2007
6Communicable Diseases (Infectious Diseases)
04/2022 - 09/2013
6Multiple Myeloma
09/2021 - 08/2014
5Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2020 - 01/2012
4Hodgkin Disease (Hodgkin's Disease)
07/2018 - 01/2013
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 01/2015
3Graft vs Host Disease (Graft-Versus-Host Disease)
06/2018 - 11/2015
3Venous Thromboembolism
04/2018 - 08/2014
2Hemophilia A (Haemophilia)
06/2022 - 05/2022
2Neutropenia
09/2021 - 01/2017
2Thrombosis (Thrombus)
09/2021 - 11/2020
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2020 - 01/2018
2follicular Thyroid cancer
01/2020 - 06/2019
2Mycoses (Diseases, Fungus)
11/2019 - 09/2019
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2015 - 01/2012
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2009 - 11/2007
1Hematologic Diseases (Blood Diseases)
04/2022
1COVID-19
04/2022
1Asymptomatic Infections
04/2022
1Viremia
02/2022
1Nocardia Infections
01/2022
1Legionellosis
10/2021
1Renal Insufficiency (Renal Failure)
09/2021
1Obesity
09/2021
1Mucositis
08/2021
1Stomatitis
08/2021
1Pneumonia (Pneumonitis)
01/2021
1Colitis
01/2021
1Bacteremia
12/2020
1Chromosome Aberrations (Chromosome Abnormalities)
06/2020
1Aplastic Anemia (Anemia, Hypoplastic)
06/2020
1Vaccine-Preventable Diseases
01/2020
1Bronchiolitis Obliterans Syndrome
01/2020
1Hepatitis B
01/2020
1Virus Diseases (Viral Diseases)
09/2019
1Thyroid Neoplasms (Thyroid Cancer)
06/2019
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2019
1Anemia
08/2018
1Chronic Disease (Chronic Diseases)
08/2018
1Iron Deficiencies
08/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2018
1Chronic Renal Insufficiency
04/2018
1Atrial Fibrillation
04/2018
1Lung Neoplasms (Lung Cancer)
04/2018
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
08/2017
1Aspergillosis
01/2017
1Candidiasis (Moniliasis)
01/2017
1Invasive Fungal Infections
10/2016
1Human Influenza (Influenza)
12/2014

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
09/2021 - 11/2007
3Bortezomib (Velcade)FDA Link
08/2014 - 11/2007
2Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
11/2021 - 09/2019
2Adrenal Cortex Hormones (Corticosteroids)IBA
09/2020 - 01/2017
2RacivirIBA
01/2020 - 06/2019
2GemcitabineFDA Link
04/2018 - 05/2013
2Rituximab (Mabthera)FDA Link
01/2018 - 09/2013
2Micafungin (FK463)FDA Link
01/2017 - 10/2016
2LigandsIBA
05/2015 - 10/2014
2treosulfanIBA
05/2008 - 05/2007
2fludarabineIBA
05/2008 - 05/2007
1Blood Coagulation Factors (Coagulation Factor)IBA
05/2022
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2021
1Melphalan (Alkeran)FDA LinkGeneric
09/2021
1letermovirIBA
01/2021
1Proteasome InhibitorsIBA
01/2021
1ErythropoietinFDA Link
11/2020
1VitaminsIBA
11/2020
1AgglutininsIBA
11/2020
1cold agglutininsIBA
11/2020
1MethylprednisoloneFDA LinkGeneric
09/2020
1Pre-B Cell ReceptorsIBA
09/2020
1Telomerase (Telomerase Reverse Transcriptase)IBA
06/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1RNA (Ribonucleic Acid)IBA
04/2019
1Azacitidine (5 Azacytidine)FDA Link
01/2019
1Environmental BiomarkersIBA
01/2019
1idelalisibIBA
01/2018
1ibrutinibIBA
01/2018
1liposomal amphotericin BFDA Link
01/2017
1Dasatinib (BMS 354825)FDA Link
11/2015
1nilotinibFDA Link
11/2015
1KIR ReceptorsIBA
10/2014
1AnticoagulantsIBA
08/2014

Therapy/Procedure

16Therapeutics
05/2022 - 11/2007
12Hematopoietic Stem Cell Transplantation
12/2021 - 05/2007
10Drug Therapy (Chemotherapy)
04/2022 - 09/2009
8Cell Transplantation
01/2022 - 11/2015
8Stem Cell Transplantation
09/2021 - 09/2009
7Transplantation
02/2022 - 09/2013
2Central Venous Catheters
12/2021 - 03/2012
1Catheters
09/2021
1Salvage Therapy
09/2020
1Organ Transplantation
01/2020
1Duration of Therapy
11/2019
1Radiotherapy
08/2018
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2016